Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04802408 · ClinicalTrials.gov registry record · Phase 2
SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial
A Phase 2 study of Covid19 and SARS-CoV Infection, sponsored by Milton S. Hershey Medical Center.
- Active
- Registry status
- Phase 2
- Development phase
- 171
- Enrollment target
- 2
- Study locations
NCT04802408 is a Phase 2 study of Covid19 and SARS-CoV Infection that is active but no longer recruiting, run by Milton S. Hershey Medical Center. The registered enrollment target is 171 participants, below the 2,700-participant average among 94 other Covid19 trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04802408, a Phase 2 study of Covid19 and SARS-CoV Infection, is active but no longer recruiting, sponsored by Milton S. Hershey Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 171 participants
- Enrollment target
- 2
- Study locations
Study Summary
Adults (aged 18-65 years) recently diagnosed with SARS-CoV-2 infection who use a 4-day combined intervention of nasal washes with 1% baby shampoo solution and oral gargles with Listerine Antiseptic® will have a reduced SARS-CoV-2 viral load compared to those using nasal and oral washes with normal saline. This combined intervention should be acceptable, tolerable and safe in this population. To test this, investigators are conducting a trial comparing the efficacy of a number of washes in reducing the oral and nasal SARS-CoV-2 viral load among adults.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Shampoo and saline
- COMBINATION_PRODUCT Saline and Listerine
- COMBINATION_PRODUCT Shampoo and Listerine
- COMBINATION_PRODUCT Saline and Saline
Study Locations (2)
Pennsylvania
- Penn State Health Milton S. Hershey Medical Center - Hershey
- Penn State - State College
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2026-05-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04802408
The ClinicalTrials.gov registry entry for NCT04802408 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,700-participant average among 94 other Covid19 trials with a reported enrollment target (94% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Covid19 appearing as the primary indexed condition, and to 4 interventions - of which Shampoo and saline is the first listed.
NCT04802408 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04802408 about?
NCT04802408 is a clinical study titled "SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial". Adults (aged 18-65 years) recently diagnosed with SARS-CoV-2 infection who use a 4-day combined intervention of nasal washes with 1% baby shampoo solution and oral gargles with Listerine Antiseptic® will have a reduced SARS-CoV-2 viral load compared to those using nasal and oral washes with normal s...
What is the current status of trial NCT04802408?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 171 participants. The study started on 2021-10-01. Estimated completion is 2026-05-30.
What conditions does trial NCT04802408 study?
This clinical trial studies the following conditions: Covid19, SARS-CoV Infection.
What interventions are being tested in trial NCT04802408?
The interventions under investigation include: Shampoo and saline (COMBINATION_PRODUCT), Saline and Listerine (COMBINATION_PRODUCT), Shampoo and Listerine (COMBINATION_PRODUCT), Saline and Saline (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04802408?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04802408 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
Defibrotide for the Treatment of Severe COVID-19
RECRUITING · Phase 2
-
COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation
ACTIVE NOT RECRUITING · Phase 2
-
A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults
ACTIVE NOT RECRUITING · Phase 2
-
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.